09:25 AM EST - Bee Vectoring Technologies International Inc : Announces significant Research and Development advancements for its proprietary biological control agent Clonostachys rosea strain CR-7 (CR-7) use as a seed treatment solution for soybeans. This breakthrough underscores the product’s compatibility and safety on seeds, propelling it toward commercialization in the agriculture sector. Bee Vectoring Technologies International Inc
shares C.BEE are trading unchanged at $0.02.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=BEE%3ACNX&qmodStoryID=6326154631070327
